Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. - Wikidata - wikimedia - TriplyDB

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

http://www.wikidata.org/entity/Q30468279

about

Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation Management of HBV Infection in Liver Transplantation Patients Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation KASL clinical practice guidelines: management of chronic hepatitis B Prophylactic managements of hepatitis B viral infection in liver transplantation Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation Management of chronic hepatitis B before and after liver transplantation Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B.Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.Posttransplant microbiological surveillance.Late hepatic allograft dysfunction.Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Hepatitis B immune globulin: product information and nursing implications.Chronic hepatitis B: current and future treatment options.Hepatitis B: progress in the last 15 years.Prevention of recurrent hepatitis B post-liver transplantation.Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.Passive antibody therapy for infectious diseases.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues Prevention of hepatitis B virus recurrence after liver transplantation.Prophylaxis of hepatitis B infection in solid organ transplant recipients.Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.The expanding role of therapeutic antibodies.

P2860

Q24198922-FFD4201C-96BC-4D6C-AE47-F6584D989473 Q24529103-21347F4B-8439-4BFF-9856-BC7B36C63381 Q26751777-1727F355-90C5-4753-A63F-2C4BB77A8123 Q26752475-A1C72D0B-9AC3-4322-B79F-D40CBF742DCC Q26772340-A721765F-ED33-41B6-B818-9C427C05E000 Q26784241-6FA69F07-05B8-4144-B5CF-4A1D3FE1C2D9 Q27024831-1BE88D9D-C1CA-4D7D-9599-2E79C3131BA7 Q27478384-FA43BF77-FA99-4271-B4A8-3A6A1758C203 Q28344317-BFBBF123-FAE9-4BD9-BCCF-C230FF7E238C Q28375636-17225B0A-0E99-4ED0-9279-60B637D07074 Q28375660-4D937336-7B8B-4FA2-B76D-BAD40ABC97B3 Q30431207-14514E00-6F17-46FD-9B3F-955F411D4249 Q33542433-9CC7DCDE-A3E8-4973-8B08-BAB7D1766972 Q33947177-40CB972E-45CA-408C-8770-C6276EC7F2C7 Q34029115-F45DF7F7-AFB5-463A-BB7C-345E0EB6D0E1 Q34271669-F9165E71-AC77-49B3-957C-2F435F1316DE Q34426400-DF28D7FE-F782-4B66-BE17-CF644BDC04C0 Q34442045-333E1428-89B8-4E63-9362-F356E0B0F3D8 Q34499694-DE28A01B-5C0E-4F5E-AB97-CEBCECA8D956 Q34547734-7EB7EE21-B109-4659-A122-3B979EB12209 Q34687438-699844E3-2453-441B-82C6-73AFF2265675 Q34936238-A4A32B02-5283-49E8-BE6D-CCBF11AA615D Q34936261-A845E75B-97C3-4BE2-9391-AD210AED6E8E Q35076630-B898ED03-61B7-4817-8D03-3728AB2EC150 Q35110095-0B369941-CAA9-4F1A-884B-902538B3E400 Q35889582-58475F0A-3CAF-4393-AA0A-52B2D82ED889 Q36028324-58DCF81F-9378-4A5D-8D04-015239476067 Q36153966-65710DBC-C580-4003-9DF0-57D676178578 Q36442537-8BA85B58-EE97-469E-AA05-8A6282B2C472 Q36652077-6D045CC0-9734-4BEB-A791-F4D6B1AB6A16 Q36886518-CB82EC59-BEE8-48E2-9DCB-31B6F1842C0E Q37432104-B8E435C8-CFF3-413E-8414-2D7D903A9B21 Q37495757-CF51B6BD-A073-43F7-A0C2-5E6C123193A1 Q37760897-7EC34048-A1F3-4D18-8481-B293CBEBB086 Q37764964-ED13EDD2-0773-4CF4-98E6-37F52762AEB2 Q37905782-833FB065-FCA1-4C3D-8BC6-C2FB774D4289 Q38006958-6638FE12-E792-4BCB-B55A-9DAE90D5F4AD Q38088688-786B28AF-D7EA-499B-B95D-097A12A3C513 Q38177252-8787A700-5509-4C7E-9454-314C2BD35F04 Q38182645-ECF16953-AC29-4246-9D56-A8C450664EDB

P2860

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

http://www.wikidata.org/entity/Q30468279

description

1996 nî lūn-bûn

@nan

1996 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Improved outcome of orthotopic ...... gressive passive immunization.

@ast

Improved outcome of orthotopic ...... gressive passive immunization.

@en

type

label

Improved outcome of orthotopic ...... gressive passive immunization.

@ast

Improved outcome of orthotopic ...... gressive passive immunization.

@en

prefLabel

Improved outcome of orthotopic ...... gressive passive immunization.

@ast

Improved outcome of orthotopic ...... gressive passive immunization.

@en

P1433

Q30468279-80533015-2D2C-49F6-9305-CE38E5DF4399

P1476

Q30468279-95B4DE49-7E8E-4910-BEBC-F09C111488B2

P2093

Q30468279-1F683533-8EC8-47DE-9F04-A90661418139

Q30468279-30D1AD7B-7B03-49AE-890D-50B07DD7A8CE

Q30468279-53CB8B75-4570-4AA2-957B-B892A4E1AB3F

Q30468279-53DE9F7D-48DE-42F3-993F-D79FC4CF4B40

Q30468279-665DE65D-3B8F-447A-8B65-CDE7C13C8BC1

Q30468279-9C546885-29B1-416E-9053-FC65675578A0

Q30468279-C33326A5-57E7-4E4A-863A-854526973D63

Q30468279-E9A0014A-94E7-474E-9B79-61F8F9A43D3C

P304

Q30468279-6D186EB3-7143-440F-83C8-A26E59E70654

P31

Q30468279-D8F1EB38-67E5-47FB-8E4A-F4C9750FB5C3

P356

Q30468279-34361E81-A7B2-48A7-A691-B27C0819667E

P433

Q30468279-1E6518AA-D593-4A55-A954-AA998EA8FB66

P478

Q30468279-38E88BD3-5704-4BA3-8560-11C7B44BC925

P577

Q30468279-6A6D6684-1EA5-42D7-86EE-BBD135F43CDF

P698

Q30468279-4B1541F8-A207-414A-A7F6-DCDD279D052A

P921

Q30468279-16E5658C-07C9-475F-A255-54EE00ABA31B

Q30468279-829512A5-4E9A-4A0F-B6B3-FA262641ECF3

Q30468279-FDA329C5-D066-4A3B-A9B0-64915B8E4581

P356

00007890-199605150-00013

P1433

Transplantation

P1476

Improved outcome of orthotopic ...... gressive passive immunization.

@en

P2093

Caldwell SH

http://www.w3.org/2001/XMLSchema#string

Dickson RC

http://www.w3.org/2001/XMLSchema#string

Ishitani MB

http://www.w3.org/2001/XMLSchema#string

McCullough CS

http://www.w3.org/2001/XMLSchema#string

McGory RW

http://www.w3.org/2001/XMLSchema#string

Oliveira WM

http://www.w3.org/2001/XMLSchema#string

Pruett TL

http://www.w3.org/2001/XMLSchema#string

Stevenson WC

http://www.w3.org/2001/XMLSchema#string

P304

1358-1364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00007890-199605150-00013

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8629297

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

liver cirrhosis